10/30/2025
Amazing time at CPHI in Germany! Great to connect with so many partners, customers, and innovators across the pharma and biotech industry.
If we missed you there — let’s reconnect soon!
Portal Instruments develops innovative drug-delivery platforms that transform injectable medication administration. Platform in development — not for sale.
190 Fifth Street
Cambridge, MA
02141
Be the first to know and let us send you an email when Portal Instruments posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Portal Instruments:
Portal Instruments is a Series B funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. We are developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Come join us on this exciting journey of redefining chronic patient care and comfort.